Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Jefferson scientists find tumor suppressor gene protects against pre-cancerous development

03.11.2006
Cell biologists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have provided further evidence that a gene thought to play a role in suppressing tumors actually can protect against the development of pre-cancerous cell growth as well.

The researchers say that the gene, caveolin-1 (Cav-1), which they found in two major types of breast cells, could be a potential target for future drugs aimed at preventing breast cancer. The work also suggests a potentially important role of the tumor "microenvironment" in the cancerous process.

Cav-1 is involved in breast cancer onset and progression, and it's present in epithelial cells and mammary "fat pads," or stromal cells. The researchers, led by Michael Lisanti, M.D., Ph.D., professor of cancer biology at Jefferson Medical College of Thomas Jefferson University and Jefferson's Kimmel Cancer Center, showed striking effects in mice that lacked Cav-1, particularly in stromal cells.

Reporting November 1, 2006 in the American Journal of Pathology, Dr. Lisanti, Kimmel Cancer Center director Richard Pestell, M.D., Ph.D., professor and chair of cancer biology at Jefferson Medical College, and their co-workers showed in a series of experiments that tumor cells grew larger in mammary fat pads lacking Cav-1, and that metastatic breast cancer cells transplanted to fat pads with Cav-1 failed to grow.

"There could also be human conditions where loss of Cav-1 in the stroma could be predisposing patients toward increased risk," Dr. Lisanti says. "This provides the hard genetic evidence of a cause-effect relationship between loss of Cav-1 in the stroma and tumor growth. This could be predictive by looking at Cav-1 in the stroma and seeing if this is a bad risk factor."

The researchers found that mice lacking the Cav-1 gene showed a cell thickening in the breast duct and hyperplasia – or excessive cell growth – in the lobulo-alveolar area. Both are locations where breast cancer can begin.

In one study, they took a tumor from a mouse and put it in a stromal fat pad in both a normal mouse and in a mouse lacking Cav-1 and discovered that the tumor grew twice as large in the latter. "The stroma clearly has effects on normal mammary growth, hyperplasia and tumorigenesis," Dr. Lisanti says.

Dr. Lisanti and his team performed another experiment in which they compared the effects of implanting metastatic breast cancer cells in mice with Cav-1 and those lacking the gene. When they implanted such cells in the mouse flank, which is not a location at which tumors grow, nothing happened. But when they put the cells in the mammary fat pad, tumors formed. When they implanted metastatic breast cancer cells with Cav-1 in the fat pads, "it had a huge effect," Dr. Lisanti says, blocking tumor growth.

"This tumor suppressor effect of Cav-1 depends on the location of the cells," he explains. "This means it is specific to the mammary fat pad. The mammary stromal and epithelial cells somehow sense the microenvironment and respond to the Cav-1 gene."

The researchers believe that the effect also depends on the activity of the cyclin D1 gene, a cancer-causing gene overexpressed in about half of all breast cancers. Using a mouse model of premalignant growth in mice carrying the cyclin D1 gene but lacking Cav-1 – which worsens the condition – the researchers added Cav-1 and found "it completely represses the phenotype, meaning it can not only suppress the tumor, but also the premalignant state caused by cyclinD1 upregulation."

Turning down cyclinD1 activity relies on the cellular microenvironment, Dr. Lisanti says. "We think Cav-1 can block the transforming effects of cyclinD1," he says. "It could be a very important therapeutic candidate for developing caveolin mimetic drugs suppressing cyclinD1 activity."

Dr. Lisanti believes that Cav-1 "could be important for early intervention because patients with epithelial cell hyperplasia could be given Cav-1 mimetic drugs to see if they could suppress this."

Steve Benowitz | EurekAlert!
Further information:
http://www.jefferson.edu

Further reports about: Cav-1 HDL-cholesterol Lisanti breast cyclinD1 mammary stroma stromal

More articles from Life Sciences:

nachricht How brains surrender to sleep
23.06.2017 | IMP - Forschungsinstitut für Molekulare Pathologie GmbH

nachricht A new technique isolates neuronal activity during memory consolidation
22.06.2017 | Spanish National Research Council (CSIC)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Quantum thermometer or optical refrigerator?

23.06.2017 | Physics and Astronomy

A 100-year-old physics problem has been solved at EPFL

23.06.2017 | Physics and Astronomy

Equipping form with function

23.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>